Bordeaux, France / April 19th, 2022 – TreeFrog Therapeutics, a biotechnology company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced the launch of The Stem Cell SpaceShot Grant, a $100,000 research funding in the field of stem cell biology and regenerative medicine. [Read more…]
Treefrog Therapeutics Expands Board with New Independent Members from the Cell Therapy Industy
• Melissa Carpenter, PhD, Chief Scientific Officer of US-based cell & gene therapy biotech ElevateBio’s Regenerative Medicine unit, joins as independent board member.
AASCP Confirms Joseph Purita, MD, as Keynote Speaker for Its Upcoming Meeting on June 17-19 in Miami, Florida
Speakers at the AASCP’s annual conference are experts from across the country in stem cell research, lecturing on the recent innovations.
April 16, 2022, MIAMI, Florida – The American Academy of Stem Cells Physicians will be back at the Hyatt Hotel for its annual conference this June 17-19, 2022. The Academy is honored to confirm Dr. Joseph Purita, one of the most well known experts within the regenerative field, for the event. “The Academy is proud to offer state-of-the-art Regenerative workshops, lead by leaders with over 100 years of combined experience,” said Dr. Sunny Kim, President of the AASCP. [Read more…]
Avery Therapeutics, Inc Announces a Publication in Nature Scientific Reports Outlining Methods of Acquiring Cardiac MRI Endpoints in High Value Pre-Clinical Models of Heart Failure from University of Arizona Study
TUCSON, Ariz., – April 11, 2022 – Avery Therapeutics, Inc. (Avery), a privately held, pre-clinical stage therapeutics company, today announced a publication in the peer-reviewed scientific journal, Nature Scientific Reports, outlining a novel technique in cardiac magnetic resonance imaging (CMR) data acquisition utilizing smart-signal gradient recalled echo (GRE)-based array sequences, entitled, “Free-breathing gradient recalled echo-based CMR in a swine heart failure model,” (Morris, el al. (2022). Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-07611-8). [Read more…]
TreeFrog Therapeutics opens technological hub in Kobe, Japan, to drive partnerships opportunities in the field of iPSC-derived cell therapies
April 8th, 2022, Kobe, Japan – TreeFrog Therapeutics, a French-based biotech company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced the incorporation of its Japanese subsidiary (KK) TreeFrog Therapeutics Japan and the establishment of a lab in Kobe, at the Creative Lab for Innovation Kobe (CLIK). [Read more…]
- « Previous Page
- 1
- …
- 59
- 60
- 61
- 62
- 63
- …
- 117
- Next Page »